Latest Articles

Publication Date
All News Scientific
Mismatch Repair-Deficient FIGO Stage IA Endometrial Adenocarcinoma With Negative Nodal Biopsy Presenting as Isolated Orbital Metastasis - Cureus

Mismatch Repair-Deficient FIGO Stage IA Endometrial Adenocarcinoma With Negative Nodal Biopsy Presenting as Isolated Orbital Metastasis Cureus

Published: April 30, 2025, 12:42 a.m.
Read Full Article
Robotic Laparoscopy Beneficial in Endometrial Cancer - Physician's Weekly

Robotic Laparoscopy Beneficial in Endometrial Cancer Physician's Weekly

Published: April 29, 2025, 8:46 p.m.
Read Full Article
Endometrial Ablation Market to Benefit from Technological Innovations and Healthcare Modernization - openPR.com

Endometrial Ablation Market to Benefit from Technological Innovations and Healthcare Modernization openPR.com

Published: April 24, 2025, 6:22 a.m.
Read Full Article
‘It’s a disaster’: Trans woman who claimed her breastmilk can ‘benefit’ babies feels ‘sexless’ after Supreme Court ruling - MSN

‘It’s a disaster’: Trans woman who claimed her breastmilk can ‘benefit’ babies feels ‘sexless’ after Supreme Court ruling MSN

Published: April 19, 2025, 1:26 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.
Read Full Article
‘It’s a disaster’: Trans woman who claimed her breastmilk can ‘benefit’ babies feels ‘sexless’ after Supreme Court ruling - GB News

‘It’s a disaster’: Trans woman who claimed her breastmilk can ‘benefit’ babies feels ‘sexless’ after Supreme Court ruling GB News

Published: April 17, 2025, 11:02 p.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Florence Pugh Stuns In A Dreamy Tulle Veil For ‘Harper’s Bazaar’ Photoshoot As Fans React: ‘Insanely Stunning’ - SHEfinds

Florence Pugh Stuns In A Dreamy Tulle Veil For ‘Harper’s Bazaar’ Photoshoot As Fans React: ‘Insanely Stunning’ SHEfinds

Published: April 16, 2025, 11:30 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!